Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial.
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial. Nat Med. 2021 10; 27(10):1818-1824.
-
Neal Lakdawala, M.D.
-
Renee Margossian, M.D.
-
Steven D. Colan, M.D.
-
E. John Orav, Ph.D.
-
Eugene Braunwald, M.D.
-
Calum Archibald MacRae, Ph.D., M.D.
-
Scott David Solomon, M.D.
-
Christine Edry Seidman, M.D.
-
Carolyn Yung Ho, M.D.